Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Common Stock Issuable [Member]
Additional Paid-in Capital [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Total
Beginning balance, value at Jun. 30, 2021 $ 5,000 $ 14,056 $ 54,074,110 $ (58,199,466) $ 1,085,204 $ (46,477) $ (3,067,573)
Beginning balance, shares at Jun. 30, 2021 500,000 1 14,055,393 59            
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest $ 9,445 190,741 200,186
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest, shares     9,445,009              
Issuance of common stock for services and accrued expenses $ 17,934 563,927 581,861
Issuance of common stock for services and accrued expenses, shares     17,934,379              
Issuance of common stock for exercise of warrants $ 7 $ 2 374,991 (100,000) 275,000
Issuance of common stock for exercise of warrants, shares     6,875 2,500            
Issuance of common stock for alternate cashless exercise of warrants $ 2,400 $ 2,000 (4,400)
Issuance of common stock for alternate cashless exercise of warrants, shares     2,399,988 1,999,990            
Reclassification of put premium upon debt conversion 109,643 109,643
Stock based compensation in connection with stock option grants 20,718 20,718
Foreign currency translation gain 64,193 64,193
Deemed dividend upon alternate cashless exercise of warrants 114,844 (114,844)
Net loss (490,658) (490,658)
Reclassification of put premium upon debt conversion                   109,643
Ending balance, value at Sep. 30, 2021 $ 5,000 $ 43,842 $ 2,002 55,444,574 (100,000) (58,804,968) 1,149,397 (46,477) (2,306,630)
Ending balance, shares at Sep. 30, 2021 500,000 1 43,841,644 2,002,549            
Beginning balance, value at Jun. 30, 2022 $ 5,000 $ 220,351 $ 19,597 57,124,982 (23,758) (61,557,893) 1,234,549 (46,477) (3,023,649)
Beginning balance, shares at Jun. 30, 2022 500,000 1 220,350,921 19,597,024            
Issuance of common stock for exercise of warrants $ 1 $ 1 99,998 100,000
Issuance of common stock for exercise of warrants, shares     1,250 1,250            
Issuance of common stock for alternate cashless exercise of warrants $ 158,399 (158,399)
Issuance of common stock for alternate cashless exercise of warrants, shares     158,399,208              
Foreign currency translation gain 126,396 126,396
Deemed dividend upon alternate cashless exercise of warrants 389,235 (389,235)
Net loss (617,295) (617,295)
Issuance of common stock for cash $ 14,337 10,374 23,758 48,469
Issuance of common stock for cash, shares     14,336,712              
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest $ 264,493 192,446 456,939
Issuance of common stock for conversion of convertible debt, conversion fee and accrued interest, shares     264,492,661              
Issuance of common stock for issuable shares $ 19,597 $ (19,597)
Issuance of common stock for issuable shares, shares     19,596,965 (19,596,965)            
Reclassification of put premium upon debt conversion 133,646 133,646
Stock based compensation in connection with stock warrant grant 2,408 2,408
Stock warrant grant for settlement of accounts payable 5,551 5,551
Ending balance, value at Sep. 30, 2022 $ 5,000 $ 677,178 $ 1 $ 57,800,241 $ (62,564,423) $ 1,360,945 $ (46,477) $ (2,767,535)
Ending balance, shares at Sep. 30, 2022 500,000 1 677,177,717 1,309